Gilead Provides Update on Phase 3 TROPiCS-04 Study

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/13/2026

1. USO
2. SPY
3. BIIB
4. AAPL
5. QTTB
6. MU
7. IONS
8. FFAI
9. DIS
10. NFLX

Go back to Gilead Provides Update on Phase 3 TROPiCS-04 Study
Gilead Sciences (NASDAQ: GILD) Delayed: 130.54 +0.71 (0.55%)
Previous Close $129.83    52 Week High $108.63 
Open $129.66    52 Week Low $71.39 
Day High $130.63    P/E 72.12 
Day Low $127.94    EPS $1.81 
Volume 907,891